The Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Wednesday, as follows:

Bed Bath & Beyond Inc. (NASDAQ:BBBY) was reiterated as Outperform and the target price was raised to 18 from 16 at Wedbush Securities. Its consensus target price was at 13.54.

DuPont de Nemours Inc. (NYSE:DD) was reiterated as Buy and the target price was raised to 91 from 86 at UBS.

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) was reiterated as Outperform at Credit Suisse, and the firm raised its target to 141 from 87 after noting that its OCA is uniquely positioned in the NASH space with an 22 April 2020, PDUFA at the FDA.

Liberty Braves Group (NASDAQ:BATRA) was started as Buy with a 35 target price at Benchmark.

Lindblad Expeditions Holdings Inc. (NASDAQ:LIND) was initiated as Buy and a 19 target price at Janney, with the firm noting that it is an attractive growth story with positive industry dynamics.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :